Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus.
J Cancer Res Clin Oncol. 2023 Jul;149(7):4131-4139. doi: 10.1007/s00432-022-04329-y. Epub 2022 Aug 30.
J Cancer Res Clin Oncol. 2023.
PMID: 36042047
Free PMC article.
Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes.
Pęksa R, Kunc M, Popęda M, Piątek M, Bieńkowski M, Żok J, Starzyńska A, Perdyan A, Sowa M, Duchnowska R, Biernat W.
Pęksa R, et al.
Cancers (Basel). 2021 Apr 7;13(8):1750. doi: 10.3390/cancers13081750.
Cancers (Basel). 2021.
PMID: 33916925
Free PMC article.
Item in Clipboard
Cite
Cite